Literature DB >> 26700766

LZTFL1 Upregulated by All-Trans Retinoic Acid during CD4+ T Cell Activation Enhances IL-5 Production.

Hong Jiang1, Kanyarat Promchan1, Bor-Ruei Lin1, Stephen Lockett2, De Chen2, Heather Marshall1, Yunden Badralmaa1, Ven Natarajan3.   

Abstract

Retinoic acids, which are metabolites of vitamin A, have been shown to be involved in multiple T cell effector responses through their binding to the retinoic acid receptor, a ligand-activated transcription factor. Because the molecular mechanism of regulation by retinoic acid is still not fully uncovered, we investigated the gene expression profile of all-trans retinoic acid (ATRA)-treated human CD4(+) T cells. Leucine zipper transcription factor-like 1 (LZTFL1) was upregulated by ATRA in a dose- and time-dependent manner. The expression of LZTFL1 depended on both ATRA and TCR signaling. LZTFL1 accumulated in the plasma membrane compartment of human CD4(+) T cells, and, during immunological synapse formation, it transiently redistributed to the T cell and APC contact zone, indicating its role in T cell activation. Live-cell imaging demonstrates that at the initial stage of immunological synapse formation, LZTFL1 is concentrated at the APC contact site, and, during later stages, it relocates to the distal pole. Knockdown of LZTFL1 reduced the basal- and ATRA-induced levels of IL-5 in CD4(+) T cells, and overexpression of LZTFL1 enhanced the TCR-mediated NFAT signaling, suggesting that LZTFL1 is an important regulator of ATRA-induced T cell response. Together, these data indicate that LZTFL1 modulates T cell activation and IL-5 levels.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26700766      PMCID: PMC4724573          DOI: 10.4049/jimmunol.1500719

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  T cell differentiation: a mechanistic view.

Authors:  O Avni; A Rao
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

Review 2.  Signaling pathways in Th2 development.

Authors:  Kerri A Mowen; Laurie H Glimcher
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

3.  Coordination of Rab8 and Rab11 in primary ciliogenesis.

Authors:  Andreas Knödler; Shanshan Feng; Jian Zhang; Xiaoyu Zhang; Amlan Das; Johan Peränen; Wei Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

4.  Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha.

Authors:  Jason A Hall; Jennifer L Cannons; John R Grainger; Liliane M Dos Santos; Timothy W Hand; Shruti Naik; Elizabeth A Wohlfert; David B Chou; Guillaume Oldenhove; Melody Robinson; Michael E Grigg; Robin Kastenmayer; Pamela L Schwartzberg; Yasmine Belkaid
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

5.  Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene.

Authors:  D H Zhang; L Cohn; P Ray; K Bottomly; A Ray
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway.

Authors:  Kevin M Elias; Arian Laurence; Todd S Davidson; Geoffrey Stephens; Yuka Kanno; Ethan M Shevach; John J O'Shea
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

7.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

Review 8.  Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking.

Authors:  Hekla Sigmundsdottir; Eugene C Butcher
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

9.  The LZTFL1 gene is a part of a transcriptional map covering 250 kb within the common eliminated region 1 (C3CER1) in 3p21.3.

Authors:  H Kiss; D Kedra; C Kiss; M Kost-Alimova; Y Yang; G Klein; S Imreh; J P Dumanski
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

10.  Complementary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells.

Authors:  S G Kang; J Park; J Y Cho; B Ulrich; C H Kim
Journal:  Mucosal Immunol       Date:  2010-07-21       Impact factor: 7.313

View more
  11 in total

Review 1.  The role of β-carotene and vitamin A in atherogenesis: Evidences from preclinical and clinical studies.

Authors:  Anthony P Miller; Johana Coronel; Jaume Amengual
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-21       Impact factor: 4.698

2.  Leucine zipper transcription factor-like 1 (LZTFL1), an intraflagellar transporter protein 27 (IFT27) associated protein, is required for normal sperm function and male fertility.

Authors:  Qian Huang; Wei Li; Qi Zhou; Parirokh Awasthi; Caroline Cazin; Yitian Yap; Ljiljana Mladenovic-Lucas; Bo Hu; Pancharatnam Jeyasuria; Ling Zhang; James G Granneman; Rex A Hess; Pierre F Ray; Zine-Eddine Kherraf; Ven Natarajan; Zhibing Zhang
Journal:  Dev Biol       Date:  2021-05-20       Impact factor: 3.148

3.  Lztfl1/BBS17 controls energy homeostasis by regulating the leptin signaling in the hypothalamic neurons.

Authors:  Qun Wei; Yi-Feng Gu; Qing-Jun Zhang; Helena Yu; Yan Peng; Kevin W Williams; Ruitao Wang; Kajiang Yu; Tiemin Liu; Zhi-Ping Liu
Journal:  J Mol Cell Biol       Date:  2018-10-01       Impact factor: 8.185

Review 4.  Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.

Authors:  Ji-Won Lee; In-Hee Lee; Takanori Sato; Sek Won Kong; Tadahiro Iimura
Journal:  Dev Growth Differ       Date:  2021-03-21       Impact factor: 3.063

5.  Impaired Vitamin D Signaling in T Cells From a Family With Hereditary Vitamin D Resistant Rickets.

Authors:  Fatima A H Al-Jaberi; Martin Kongsbak-Wismann; Alejandro Aguayo-Orozco; Nicolai Krogh; Terkild B Buus; Daniel V Lopez; Anna K O Rode; Eva Gravesen; Klaus Olgaard; Søren Brunak; Anders Woetmann; Niels Ødum; Charlotte M Bonefeld; Carsten Geisler
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

6.  SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.

Authors:  Lana Vukadin; Jung-Hyun Kim; Eun Young Park; Joshua K Stone; Nathan Ungerleider; Melody C Baddoo; Hyun Kyung Kong; Alexander Richard; Johnny Tran; Hannah Giannini; Erik K Flemington; Ssang-Taek Steve Lim; Eun-Young Erin Ahn
Journal:  Cancer Gene Ther       Date:  2020-11-27       Impact factor: 5.987

7.  Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib.

Authors:  Jim S Qin; Timothy G Johnstone; Alex Baturevych; Ronald J Hause; Seamus P Ragan; Christopher R Clouser; Jon C Jones; Rafael Ponce; Cecile M Krejsa; Ruth A Salmon; Michael O Ports
Journal:  J Immunother       Date:  2020-05       Impact factor: 4.912

8.  Leucine zipper transcription factor-like 1 binds adaptor protein complex-1 and 2 and participates in trafficking of transferrin receptor 1.

Authors:  Kanyarat Promchan; Ven Natarajan
Journal:  PLoS One       Date:  2020-01-02       Impact factor: 3.240

9.  Genetic Risk of Severe Covid-19.

Authors:  Arthur Kaser
Journal:  N Engl J Med       Date:  2020-10-15       Impact factor: 91.245

10.  Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren's Syndrome Patients Identifies CCL5 as a Novel Effector Molecule.

Authors:  Anneline C Hinrichs; Sofie L M Blokland; Ana P Lopes; Catharina G K Wichers; Aike A Kruize; Aridaman Pandit; Timothy R D J Radstake; Joel A G van Roon
Journal:  Front Immunol       Date:  2021-07-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.